{"id":"NCT00518180","sponsor":"Novartis Vaccines","briefTitle":"A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents","officialTitle":"A Phase 3, Single-Center, Open-label, Controlled, Randomized Study to Evaluate the Safety and Immunogenicity of Novartis Men ACWY Vaccine Administered Either Alone or Concomitantly With a Combined Tetanus, Reduced Diphtheria Toxoid, Acellular Pertussis Vaccine and Quadrivalent Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine in Healthy Adolescents","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2008-04","completion":"2008-10","firstPosted":"2007-08-20","resultsPosted":"2010-10-04","lastUpdate":"2016-05-18"},"enrollment":1620,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Meningococcal Meningitis","Human Papillomavirus Infection","Pertussis","Tetanus"],"interventions":[{"type":"BIOLOGICAL","name":"Novartis Meningococcal ACWY Conjugate Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Tdap Vaccine","otherNames":[]},{"type":"BIOLOGICAL","name":"Novartis Meningococcal ACWY Conjugate Vaccine","otherNames":[]}],"arms":[{"label":"MenACWY + Tdap + HPV","type":"EXPERIMENTAL"},{"label":"MenACWY →Tdap → HPV","type":"EXPERIMENTAL"},{"label":"Tdap →MenACWY → HPV","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine when administered with Tdap and HPV vaccinations to healthy adolescents","primaryOutcome":{"measure":"Percentage of Subjects With Human Serum Bactericidal Assay (hSBA) Seroresponse","timeFrame":"1 month post MenACWY vaccination","effectByArm":[{"arm":"MenACWY+Tdap+HPV","deltaMin":80,"sd":null},{"arm":"MenACWY→Tdap→HPV","deltaMin":82,"sd":null},{"arm":"Tdap →MenACWY → HPV","deltaMin":87,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null},{"comp":"OG001 vs OG002","p":null}]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":1,"countries":["Costa Rica"]},"refs":{"pmids":["20189491"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":540},"commonTop":["INJECTION SITE PAIN Tdap","INJECTION SITE PAIN HPV","HEADACHE","INJECTION SITE PAIN MENVEO","MALAISE"]}}